Med. praxi. 2015;12(4):162-165

The significance of treatment of anemia in patients with heart failure

prof.MUDr.Jiří Vítovec, CSc., FESC1, prof.MUDr.Jindřich ©pinar, CSc.2, prof.MUDr.Lenka ©pinarová, Ph.D., FESC1
1 1. interní kardioangiologická klinika Lékařské fakulty MU a FN u sv. Anny v Brně
2 Interní kardiologická klinika Lékařské fakulty MU, FN Brno

Anemia with iron deficiency is an important co-morbidity in patients with heart failure. A major factor in the pathogenesis of anaemia,

it is also a separate condition with serious clinical consequences (e.g. impaired exercise capacity) and poor prognosis in heart failure

patients. Clinical studies have demonstrated favourable effects of intravenous iron on the functional status, quality of life, and exercise

capacity in heart failure patients. Intravenous iron supplementation becomes a novel therapy in heart failure patients with iron deficiency.

Keywords: anaemie, iron deficiency, heart failure, therapy of anaemie

Published: September 19, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec J, ©pinar J, ©pinarová L. The significance of treatment of anemia in patients with heart failure. Med. praxi. 2015;12(4):162-165.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Krč I. Diagnostika nejběľnějąích typů anémie. Interní medicína pro praxi 2001; 2: 84-88.
    2. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006; 113: 2454-2461. Go to original source... Go to PubMed...
    3. Hradec J. Anémie při chronickém srdečním selhání. Vnitř Lék 2010; 56(8): 854-855. Go to PubMed...
    4. Kosiborod M., CurtisJ.P., Wang Y. et al. Anemia and Outcomes in Patients With Heart Failure. Arch Intern Med. 2005; 165: 2237-2244. Go to original source... Go to PubMed...
    5. Jankowska EA, von Haehling S, Anker SD, et al. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013; 34: 816-826. Go to original source... Go to PubMed...
    6. Nanas JN, Matsouka C, Karageorgopoulos D, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006; 48: 2485-2489. Go to original source... Go to PubMed...
    7. Westenbrink BD, de Boer RA, Voors AA, et al. Anemia in chronic heart failure: etiology and treatment options. Curr Opin Cardiol 2008; 23: 141-147. Go to original source... Go to PubMed...
    8. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011; 434: 365-381. Go to original source... Go to PubMed...
    9. Goddard AF, James MW, McIntyre AS, Scott BB. on behalf of the Brit Soc Gastroenterol. Guidelines for the management of iron deficiency anaemia. Gut 2011; 60: 1309-1316. Go to original source... Go to PubMed...
    10. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010; 31: 1872-1880. Go to original source... Go to PubMed...
    11. Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007; 50: 1657-1665. Go to original source... Go to PubMed...
    12. Okonko DO, Grzeslo A, Witkowski T, et al.Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: J Am Coll Cardiol 2008; 51: 103-112.. Go to original source... Go to PubMed...
    13. Anker SD Comin-Colet J, Filipptos G, et al. FAIRHF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448.. Go to original source... Go to PubMed...
    14. Ponikovski P, van Veldhuisen DJ. Comin-Colet J. et al. for the CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 2015; 36: 657-668. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.